Atorvastatin affects low density lipoprotein and non-high density lipoprotein cholesterol relations with apolipoprotein B in type 2 diabetes mellitus: modification by triglycerides and cholesteryl ester transfer protein

Paul JWH Kappelle University Medical Centre Groningen, Department of Endocrinology, P.O. Box 30001 9700 RB Groningen, The Netherlands +31 503613731; +31 503611977; [email protected]

Louwerens Zwang Erasmus Medical Centre, Department of Clinical Chemistry, Rotterdam, The Netherlands

Menno V Huisman Leiden University Medical Center, Department of General Internal Medicine- Endocrinology, Section Vascular Medicine, Leiden, The Netherlands

Jan Dirk Banga Hospital Gelderse Vallei Ede, The Netherlands

Wim J Sluiter University Medical Centre Groningen, Department of Endocrinology, P.O. Box 30001 9700 RB Groningen, The Netherlands +31 503613731; +31 503611977; [email protected]

Geesje M Dallinga-Thie Academic Medical Center Amsterdam, Laboratory of Experimental Vascular Medicine, Amsterdam, The Netherlands

Robin PF Dullaart for the Diabetes Atorvastatin Lipid Intervention (DALI) study group University Medical Centre Groningen, Department of Endocrinology, P.O. Box 30001 9700 RB Groningen, The Netherlands +31 503613731; +31 503611977; [email protected]

show all

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (7)

Qiuzhen Lin, Yan Fu, XueYan Zang, Qiming Liu & Ling Liu. (2021) The Role of Fasting LDL-C Levels in Their Non-fasting Reduction in Patients With Coronary Heart Disease. Frontiers in Cardiovascular Medicine 8.
Crossref

Muhammad Ismail Shawish, Bahador Bagheri, Vijaya M Musini, Stephen P Adams & James M Wright. (2021) Effect of atorvastatin on testosterone levels. Cochrane Database of Systematic Reviews 2021:1.
Crossref

James P. Corsetti, Ron T. Gansevoort, Stephan J.L. Bakker, Charles E. Sparks, Priya Vart & Robin P.F. Dullaart. (2014) Apolipoprotein B Attenuates Albuminuria-Associated Cardiovascular Disease in Prevention of Renal and Vascular Endstage Disease (PREVEND) Participants. Journal of the American Society of Nephrology 25:12, pages 2906-2915.
Crossref

Fiona Taylor, Mark D Huffman, Ana Filipa Macedo, Theresa HM Moore, Margaret Burke, George Davey Smith, Kirsten Ward, Shah Ebrahim & Hawkins C Gay. (2013) Statins for the primary prevention of cardiovascular disease. Cochrane Database of Systematic Reviews 2021:9.
Crossref

P. J. W. H. Kappelle, R. T. Gansevoort, J. L. Hillege, B. H. R. Wolffenbuttel & R. P. F. Dullaart. (2011) Apolipoprotein B/A-I and total cholesterol/high-density lipoprotein cholesterol ratios both predict cardiovascular events in the general population independently of nonlipid risk factors, albuminuria and C-reactive protein. Journal of Internal Medicine 269:2, pages 232-242.
Crossref

John C. Rutledge, Kit F. Ng, Hnin H. Aung & Dennis W. Wilson. (2010) Role of triglyceride-rich lipoproteins in diabetic nephropathy. Nature Reviews Nephrology 6:6, pages 361-370.
Crossref

Shizuya Yamashita, Kazumi Tsubakio-Yamamoto, Tohru Ohama, Yumiko Nakagawa-Toyama & Makoto Nishida. (2010) Molecular Mechanisms of HDL-Cholesterol Elevation by Statins and Its Effects on HDL Functions. Journal of Atherosclerosis and Thrombosis 17:5, pages 436-451.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Atorvastatin affects low density lipoprotein and non-high density lipoprotein cholesterol relations with apolipoprotein B in type 2 diabetes mellitus: modification by triglycerides and cholesteryl ester transfer protein

Articles from other publishers (7)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Atorvastatin affects low density lipoprotein and non-high density lipoprotein cholesterol relations with apolipoprotein B in type 2 diabetes mellitus: modification by triglycerides and cholesteryl ester transfer protein

Citations (7)

Articles from other publishers (7)

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date